Prism Medico and Pharmacy Share Price
12 Aug, 2026 4:01 PM (IST)
Prism Medico and Pharmacy Performance
- Today's Low
- ₹27
- Today's High
- ₹28
- 52 Week Low
- ₹13
- 52 Week High
- ₹35
- Open Price₹28
- Previous Close₹27
- Volume12,262
- 50 DMA₹28.00
- 100 DMA₹27.30
- 200 DMA₹25.10
Prism Medico and Pharmacy Chart
Investment Returns
- Over 1 Month -5.21%
- Over 3 Month -13.85%
- Over 6 Month + 50.17%
- Over 1 Year + 85.71%
Smart Investing Starts Here Start SIP with Prism Medico and Pharmacy for Steady Growth!
Prism Medico and Pharmacy Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -93.2
- PEG Ratio
- 0.6
- Market Cap Cr
- 37
- P/B Ratio
- 1.6
- Average True Range
- 2.2
- EPS
- -0.3
- Dividend Yield
- 0
- MACD Signal
- -0.3
- RSI
- 46.8
- MFI
- 46.25
Latest Stock News Updates
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 12th August, 2026) which commenced at 01:30 P.M. and concluded at 03:30 P.M. have inter alia approved the following: ? The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter ended 30th June, 2026 alongwith the Limited Review Report duly signed by the Auditors of the company. You are requested to kindly take the same on record and oblige.
- BSE India
- 8 hours 32 minutes ago
Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter ended 30th June, 2026, as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- BSE India
- 1 week ago
Dear Sir/Madam, This is to inform you that the website of M/s. Prism Medico and Pharmacy Limited is updated and functional as per Regulation 46 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The website of the company is http://www.prismmedico.in. You are requested to kindly take the same on record and oblige. Thank you.
- BSE India
- 1 week 6 days ago
Prism Medico and Pharmacy Financials
Prism Medico and Pharmacy Technicals
EMA & SMA
- Bearish Moving Average 11
- Bullish Moving Average 5
- 20 Day
- ₹27.80
- 50 Day
- ₹28.00
- 100 Day
- ₹27.30
- 200 Day
- ₹25.10
Resistance and Support
- R3 29.90
- R2 29.00
- R1 28.20
- S1 26.50
- S2 25.60
- S3 24.80
Prism Medico and Pharmacy Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-12 | Quarterly Results | |
| 2026-05-28 | Audited Results | |
| 2026-02-13 | Quarterly Results | |
| 2025-11-14 | Quarterly Results | |
| 2025-09-05 | Others | Inter-alia, to consider 1. Fix day, date, time and Notice for holding the 23rd AGM. 2. Director's Report along with all necessary annexures thereof. 3. Other business matters. |
About Prism Medico and Pharmacy
Prism Medico and Pharmacy engaged in wholesale and retail altering its Memorandum of Association to enter the pharmaceutical and healthcare sectors. Its current activities include manufacturing, processing, and trading pharmaceuticals, antibiotics, nutraceuticals, and other health-related products for both domestic and international markets. View More- NSE Symbol
- PRISMMEDI
- BSE Symbol
- 512217
- ISIN
- INE730E01016
Similar Stocks to Prism Medico and Pharmacy
Popular Stocks
Prism Medico and Pharmacy FAQs
Prism Medico and Pharmacy share price is ₹27 As on 13 August, 2026 | 00:06
The Market Cap of Prism Medico and Pharmacy is ₹37 Cr As on 13 August, 2026 | 00:06
The P/E ratio of Prism Medico and Pharmacy is -93.2 As on 13 August, 2026 | 00:06
The PB ratio of Prism Medico and Pharmacy is 1.6 As on 13 August, 2026 | 00:06
The 52 week High & Low of Prism Medico and Pharmacy is ₹34.5/₹13.1 respectively As on 13 August, 2026 | 00:06
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.